Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
07 03 2022
07 03 2022
Historique:
received:
27
09
2021
accepted:
12
12
2021
entrez:
6
4
2022
pubmed:
7
4
2022
medline:
9
4
2022
Statut:
epublish
Résumé
Modest improvements in household water, sanitation, and hygiene (WASH) and typhoid vaccination can reduce typhoid risk in endemic settings. However, empiric evaluation of their combined impact is lacking. A total of 62,756 persons residing in 80 clusters in a Kolkata slum were allocated randomly 1:1 to either the typhoid Vi polysaccharide (ViPS) vaccine or hepatitis A (Hep A) vaccine. Surveillance was conducted for 2 years before and 2 years after vaccination. We classified households as having "better" or "not better" WASH, and calculated the prevalence of better WASH households in clusters using previously validated criteria. We evaluated the protection by better household WASH, better household WASH prevalence, and ViPS vaccination against typhoid in all cluster members present at baseline using Cox proportional hazard models. Overall, ViPS vaccination was associated with a 55% (P < 0.001; 95% CI, 35-69) reduction of typhoid risk and was similar regardless of better WASH in the residence. Living in a better WASH household was associated with a typhoid risk reduction of 31% (P = 0.16; 95% CI, -16 to 59) overall. The reduction was 48% (P = 0.05; 95% CI, -1 to 73) in Hep A clusters, 6% (P = 0.85; 95% CI, -82 to 51) in ViPS clusters, and 57% (P < 0.05; 95% CI, 15-78) in the population during the 2 years preceding the trial. These findings demonstrate a preventive association of better household WASH in the non-ViPS population, but, unexpectedly, an absence of additional protection from ViPS by better WASH in the ViPS population. This analysis highlights the importance of assessing the combination of WASH in conjunction with typhoid vaccines, and has implications for the evaluation of new-generation typhoid conjugate vaccines.
Identifiants
pubmed: 35385827
doi: 10.4269/ajtmh.21-1034
pii: tpmd211034
pmc: PMC8991341
doi:
pii:
Substances chimiques
Dietary Carbohydrates
0
Typhoid-Paratyphoid Vaccines
0
Water
059QF0KO0R
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1149-1155Références
Clin Infect Dis. 2021 Jun 1;72(11):e720-e726
pubmed: 32964216
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
Bull World Health Organ. 2001;79(7):625-31
pubmed: 11477965
Demography. 2005 Feb;42(1):1-22
pubmed: 15782893
Lancet. 1987 Nov 21;2(8569):1165-9
pubmed: 2890805
Lancet Glob Health. 2017 Oct;5(10):e969
pubmed: 28911760
Bull World Health Organ. 1971;44(5):667-72
pubmed: 5316750
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Lancet Glob Health. 2014 Oct;2(10):e570-80
pubmed: 25304633
Lancet Infect Dis. 2019 Apr;19(4):369-381
pubmed: 30792131
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S130-S137
pubmed: 30845337
N Engl J Med. 2009 Jul 23;361(4):335-44
pubmed: 19625715
N Engl J Med. 1987 Oct 29;317(18):1101-4
pubmed: 3657877